文献速递中枢神经肿瘤放疗头颈部肿瘤放疗放疗物理与技术

基于视野缺损的多变量NTCP模型预测质子治疗早期放射性视神经病变

Multivariable Normal Tissue Complication Probability Prediction of Early Grade Radiation-Induced Optic Neuropathy Using Visual Field Deficit in a Prospective Pencil Bean Scanning Proton Therapy Cohort.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2025-11-23

这项前瞻性研究纳入105例放疗前无或轻微视野缺损的患者(179只眼),采用铅笔束扫描质子治疗,中位随访3.6年,23.5%的眼发生2级及以上放射性视神经病变(RION),中位发生时间12.1个月。整合剂量组学的随机森林模型预测AUC达0.8,基线视野缺损和视交叉V50是最强预测因子。

要点

  • 质子治疗队列中2级及以上RION发生率为23.5%,中位发生时间12.1个月。
  • 整合剂量组学的随机森林模型预测RION的AUC为0.8,优于Lyman-Kutcher-Burman模型(AUC=0.5)。
  • 基线轻微视野缺损和视交叉V50>50%是RION最强预测因子。

核心结论

  • 前瞻性标准化视野评估显示2级及以上RION风险为23.5%,性别、血管合并症、肿瘤压迫或手术所致视路预存损伤及视交叉剂量是RION危险因素。

研究设计与样本

  • 前瞻性研究纳入105例旁视路头颈肿瘤或中枢神经系统肿瘤患者(179只眼),基线及每半年行标准化眼科评估,分析视神经、视交叉和视网膜剂量学。
  • 采用多共线性削减和逐步特征选择构建逻辑回归与随机森林预测模型,RION定义为视野缺损低于-6 dB(2级及以上)。

主要发现

  • 105例患者中42/105(23.5%)眼发生2级及以上RION,中位随访3.6年,中位发生时间12.1个月。
  • Lyman-Kutcher-Burman模型预测价值差(AUC=0.5),整合剂量组学的随机森林模型AUC为0.8。
  • RION与年龄(R=0.24,P<.001,弱)、高血压(R=0.23,P=.002,弱)、胆固醇水平(R=0.24,P=.004,弱)及基线视野平均缺损(R=-0.39,P<.001,中度)相关。
  • 基线轻微缺损患者发生RION风险为无缺损者的3.29倍(95%CI 2.87-3.38),视交叉V50>50%者风险为V50<50 Gy者的1.59倍(95%CI 1.54-1.61)。
  • 女性NTCP高于男性(29.8% vs 21.0%;95%CI分别为25.0%-34.6%和17.1%-24.9%),高胆固醇血症(36.7% vs 24.7%)和高血压(36.3% vs 24.2%)患者NTCP亦升高。

关键数值与推荐

  • RION定义为视野缺损低于-6 dB(2级及以上)。
  • 基线轻微视野缺损者RION风险为无缺损者的3.29倍(95%CI 2.87-3.38)。
  • 视交叉V50>50%者RION风险为V50<50 Gy者的1.59倍(95%CI 1.54-1.61)。

临床怎么用

  • 对旁视路头颈肿瘤及中枢神经系统肿瘤质子治疗患者,应基线和定期行定量视野检查以识别早期RION。
  • 规划时关注视交叉V50,结合基线视野状态、性别及血管合并症进行NTCP个体化预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Radiation-induced optic neuropathy (RION) occurs in about 4% of extraocular tumors. Current predictive models reliably identify grade-4 RION when blindness is irreversible. We developed a sensitive multivariable Normal Tissue Complication Probability (NTCP) model integrating quantitative visual outcomes and dosiomics to predict earlier grade 2+ RION in a pencil beam scanning proton therapy cohort. METHODS AND MATERIALS: This prospective study included patients with paraoptic head and neck cancer and patients with central nervous system tumor who underwent standardized ophthalmologic assessments at baseline and semiannually. Dosimetry for the optic nerves, chiasm, and retinas was analyzed. RION was defined as a visual field deficit below -6 dB (grade 2+). Predictive models-including logistic regression and random forest-were developed with multicollinearity reduction and stepwise feature selection to identify the most relevant predictors of RION. RESULTS: Of 238 patients, 105 had no/minor visual deficit before irradiation (179 eyes, median age 58.1 years) and were analyzed; 42/105 (23.5%) eyes developed grade 2+ RION over a 3.6-year median follow-up, with onset at 12.1 months. Lyman-Kutcher-Burman models had poor predictive value (area under the curve = 0.5). RION correlated with clinical features, including age (R = 0.24, P < .001, weak), hypertension (R = 0.23, P = .002, weak), cholesterol levels (R = 0.24, P = .004, weak), and baseline visual field mean deficit (R = -0.39, P < .001, moderate). Random forest models incorporating dosiomics achieved an area under the curve of 0.8. Baseline deficit (possibly by tumor compression/surgery) and optic chiasm volume receiving over 50Gy (V50 chiasma) were the strongest predictors. Patients with minor baseline deficits were 3.29-fold higher risk to RION (95% CI, 2.87-3.38) more likely to develop RION than those without deficits. A V50 chiasma above 50% was associated with 1.59 times (95% CI, 1.54-1.61) increased risk of RION compared to V50 chiasma < 50 Gy. Female patients had higher NTCP than males (29.8% vs 21.0%; 95% CI, 25.0%-34.6% and 17.1%-24.9%, respectively). NTCP was also increased in patients with hypercholesterolemia (36.7%, 95% CI, 34.2%-39.3% vs 24.7%, 95% CI, 22.1-27.3) and hypertension (36.3%, 95% CI, 33.9%-38.7% vs 24.2%, 95% CI, 21.7-26.7). CONCLUSIONS: Prospective and standardized visual assessment revealed a 23.5% risk of grade 2+ RION using visual field perimetry. Gender, vascular comorbidities, pre-existing damage from tumor compression or surgery to the optic pathways, and dose to the chiasma were risk factors for RION.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Pham TN, Azemar N, Mathis T, et al. Multivariable Normal Tissue Complication Probability Prediction of Early Grade Radiation-Induced Optic Neuropathy Using Visual Field Deficit in a Prospective Pencil Bean Scanning Proton Therapy Cohort. Int J Radiat Oncol Biol Phys. 2025. PMID: 41290050. doi:10.1016/j.ijrobp.2025.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。